California-based Shareholder Rights Law Firm Johnson & Weaver, LLP is
investigating potential violations of the federal securities laws by
Zosano Pharma Corporation (NASDAQ: ZSAN) and certain of its officers and
directors. Zosano is a California-based, clinical stage specialty
pharmaceutical company.
Specifically, Johnson & Weaver’s investigation seeks to determine
whether the Company’s filings with the U.S. Securities and Exchange
Commission in connection with its January 2015 initial public stock
offering (the “IPO”) contained untrue statements of material facts or
omitted to state other facts necessary to make the statements made
therein not misleading concerning the Company’s business and financial
prospects.
In January 2015, Zosano offered more than 6,500,000 shares of its common
stock at $11.00 per share in connection with its IPO. Just one year
later, Zosano common stock has plummeted and was trading at just $2.40
per share during intra-day trading on January 6, 2016 – almost 80% less
than its January 2015 offering price.
If you have information that could assist in this investigation, or
if you are a Zosano shareholder and are interested in learning more
about the investigation or your legal rights and remedies, please
contact Michael I. Fistel, Jr., Esq. (michaelf@johnsonandweaver.com)
by email or by phone at 770-200-3104. If emailing, please include a
phone number where you can be reached.
About Johnson & Weaver, LLP:
Johnson & Weaver, LLP is a nationally recognized shareholder rights law
firm with offices in California, New York and Georgia. The firm
represents individual and institutional investors in shareholder
derivative and securities class action lawsuits. For more information
about the firm and its attorneys, please visit http://www.johnsonandweaver.com.
Attorney advertising. Past results do not guarantee future outcomes.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160106006632/en/
Copyright Business Wire 2016